Related Experiment Video

Updated: May 11, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Treating myoclonic epilepsy in children: state-of-the-art

Pasquale Striano1, Vincenzo Belcastro

  • 1University of Genoa, G. Gaslini Institute, Maternal and Child Health, Department of Neurosciences, Pediatric Neurology and Muscular Diseases Unit, Rehabilitation, Ophtalmology, Genetics, Genova, Italy. pstriano@email.it

Expert Opinion on Pharmacotherapy
|May 15, 2013
PubMed

Insights

Treatment for myoclonic seizures often involves valproate or benzodiazepines, with newer options available. Careful drug selection is crucial, as some medications can worsen seizures, impacting patient quality of life.

Area of Science:

  • Neurology
  • Epileptology

Background:

  • Myoclonic seizures occur in various epilepsy types, both idiopathic and symptomatic.
  • Limited research exists on effective treatments for myoclonic seizures.
  • Some antiepileptic drugs can paradoxically worsen myoclonic seizures.

Purpose of the Study:

  • To review the safety, tolerability, and efficacy of antiepileptic drugs for myoclonic seizures.
  • To discuss current treatment options and emerging therapies.

Main Methods:

  • Review of safety, tolerability, and efficacy data for antiepileptic drugs with antimyoclonic effects.
  • Analysis of drug use alone and in combination therapy.

Main Results:

  • Valproate is a common first-line treatment, often combined with benzodiazepines or levetiracetam.
  • Evidence for topiramate and zonisamide monotherapy remains insufficient.
  • Avoiding medications that exacerbate seizures is critical.

Conclusions:

  • Pediatric myoclonic seizure treatment relies on limited randomized controlled trials.
  • Further research into pathophysiological mechanisms is needed for improved treatment outcomes.
  • Enhanced understanding can improve patient quality of life.
Abstract

More Related Videos

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...